Health Condition 1: null- Heart failure, Durable Left ventricular assisted device Health Condition 2: I509- Heart failure, unspecified
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: Nil: Nil
Sponsors
The international society for heart and lung transplant registry
Eligibility
Inclusion criteria
Inclusion criteria: Patients who receive a Durable Mechanical Circulatory Support Device will be included n the study
Exclusion criteria
Exclusion criteria: Patients who receive a non-durable mechanically circulatory support device (MCSD. There is no exclusion for age, gender, race, ethnicity, or any other demographic limit.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Improved outcomes from new techniques and devices 2. Facilitate accelerated evaluation of new devices 3. Development of international standards for MCS therapyTimepoint: 1 month, 3 month, and every 6 month | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: None | — |
Countries
Australia, Austria, Azerbaijan, Belarus, Belgium, Brazil, Canada, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Greece, Hong Kong, Hungary, India, Ireland, Israel, Italy, Japan, Kazakhstan, Netherlands, New Zealand, Norway, Poland, Saudi Arabia, Singapore, Slovakia, Spain, Sweden, Switzerland, Turkey, United Kingdom, United States of America
Contacts
Public ContactDr Varun Shetty
Narayana Hrudayalaya Ltd
Outcome results
None listed